Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Survival analysis of patients with idiopathic dilated cardiomyopathy in Oman.

Agarwal AK, Venugopalan P, Meharali A, de Bono D.

Saudi Med J. 2005 Feb;26(2):220-4.

PMID:
15770294
2.
3.

Prevalence and aetiology of heart failure in an Arab population.

Agarwal AK, Venugopalan P, de Bono D.

Eur J Heart Fail. 2001 Jun;3(3):301-5.

4.

Concepts in acute coronary syndromes.

Foo RS, De Bono DP.

Singapore Med J. 2000 Dec;41(12):606-10. Review.

PMID:
11296789
5.

Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.

Javed Q, Swanson N, Warner EL, Gershlick AH, de Bono DP.

Exp Mol Pathol. 2001 Apr;70(2):146-53.

PMID:
11263957
6.

Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis.

Baron JH, Moiseeva EP, de Bono DP, Abrams KR, Gershlick AH.

Cardiovasc Res. 2000 Dec;48(3):464-72.

PMID:
11090842
7.

Catecholamine levels in heart failure due to dilated cardiomyopathy and their relationship to the severity of heart failure.

Agarwal AK, Venugopalan P, Woodhouse C, de Bono D.

Eur J Heart Fail. 2000 Sep;2(3):261-3. No abstract available.

8.

In vitro evaluation of c7E3-Fab (ReoPro) eluting polymer-coated coronary stents.

Baron JH, Gershlick AH, Hogrefe K, Armstrong J, Holt CM, Aggarwal RK, Azrin M, Ezekowitz M, de Bono DP.

Cardiovasc Res. 2000 Jun;46(3):585-94.

PMID:
10912469
9.

Coronary artery disease: combined stress MR imaging protocol-one-stop evaluation of myocardial perfusion and function.

Sensky PR, Jivan A, Hudson NM, Keal RP, Morgan B, Tranter JL, de Bono D, Samani NJ, Cherryman GR.

Radiology. 2000 May;215(2):608-14.

PMID:
10796946
10.

Inhibition of platelet thrombosis using an activated protein C-loaded stent: in vitro and in vivo results.

Foo RS, Gershlick AH, Hogrefe K, Baron JH, Johnston TW, Hussey AJ, Garner I, de Bono DP.

Thromb Haemost. 2000 Mar;83(3):496-502.

PMID:
10744160
11.

Galectin 1 is involved in vascular smooth muscle cell proliferation.

Moiseeva EP, Javed Q, Spring EL, de Bono DP.

Cardiovasc Res. 2000 Jan 14;45(2):493-502.

PMID:
10728371
12.

How valuable is cardiac rehabilitation and who should get it?

Thompson DR, De Bono DP.

Heart. 1999 Nov;82(5):545-6. No abstract available.

13.

Effect of an alpha(2) agonist (mivazerol) on limiting myocardial ischaemia in stable angina.

Fox K, Dargie HJ, de Bono DP, Oliver MF, Wülfert E, Kharkevitch T.

Heart. 1999 Sep;82(3):383-5.

14.

Chronic haemoptysis as delayed complication of ventricular aneurysmectomy.

Kovac JD, Spyt TJ, Firmin RK, Verma PK, de Bono DP.

Int J Cardiol. 1999 Jun 1;69(3):299-303.

PMID:
10402113
16.

Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocardiographic RR interval but not QT dispersion.

Pedretti RF, Catalano O, Ballardini L, de Bono DP, Radice E, Tramarin R.

Int J Cardiol. 1999 Jan;68(1):83-93.

PMID:
10077405
18.

Development and future of open access echocardiography.

de Bono D.

Hosp Med. 1998 Aug;59(8):600, 602. No abstract available.

PMID:
9829049
19.

Role of transcutaneous ultrasound in evaluation of graft patency following minimally invasive coronary surgery.

Gupta S, Murgatroyd F, Widenka K, Spyt TJ, De Bono DP.

Eur J Cardiothorac Surg. 1998 Oct;14 Suppl 1:S88-92.

PMID:
9814800
20.

Olovnikov's clock: telomeres and vascular biology.

de Bono DP.

Heart. 1998 Aug;80(2):110-1. No abstract available.

21.

Preoperative and early postoperative assessment of the internal thoracic artery by transcutaneous duplex ultrasound in coronary artery bypass grafting.

Nikodemska I, De Bono DP, Spyt TJ, Wiechowski S, Nikodemski T.

Int J Cardiol. 1998 Sep 1;66(1):39-44.

PMID:
9781786
22.

Increased wound-induced platelet activation in Indo-Asians: egg, chicken, milestone?

De Bono D.

Eur Heart J. 1998 May;19(5):685-6. No abstract available.

PMID:
9716998
23.
24.

A prioritisation system for elective coronary angiography.

de Bono DP, Ravilious B, el-Zoubi I, Dyer T, Podinovskaya Y.

Heart. 1998 May;79(5):448-53.

25.

Genetic identification of antigens exposed in damaged endothelial cells as laminin-binding proteins.

Ireland DC, Spring EL, Moiseeva E, de Bono DP.

Clin Exp Immunol. 1998 May;112(2):255-61.

26.
27.

First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome.

Shaukat N, Lear J, Lowy A, Fletcher S, de Bono DP, Woods KL.

BMJ. 1998 Jan 10;316(7125):116. No abstract available.

28.

The United Kingdom pacing and cardiovascular events (UKPACE) trial. United Kingdom Pacing and Cardiovascular Events.

Toff WD, Skehan JD, De Bono DP, Camm AJ.

Heart. 1997 Sep;78(3):221-3. No abstract available.

29.

Need for improved treatment for unstable coronary artery disease.

de Bono DP.

Am J Cardiol. 1997 Sep 4;80(5A):2E-4E.

PMID:
9296461
30.

Alteplase.

de Bono D.

Expert Opin Investig Drugs. 1997 Aug;6(8):1095-8.

PMID:
15989666
31.

Drugs for cardiovascular disease. Spoilt for choice?

de Bono D.

Expert Opin Investig Drugs. 1997 Jul;6(7):915-8.

PMID:
15989654
32.
33.

Angioplasty registries: wide open for audit?

De Bono DP.

Eur Heart J. 1997 Jul;18(7):1042-3. No abstract available.

PMID:
9243130
34.

Diastolic ventricular interaction: Starling (and Bernheim) revisited.

de Bono D.

Lancet. 1997 Jun 14;349(9067):1712. No abstract available.

PMID:
9193377
35.

Cardiac rehabilitation services in England and Wales: a national survey.

Thompson DR, Bowman GS, Kitson AL, de Bono DP, Hopkins A.

Int J Cardiol. 1997 May 23;59(3):299-304.

PMID:
9183047
36.

The development and testing of a cardiac rehabilitation audit tool.

Thompson DR, Bowman GS, De Bono DP, Hopkins A.

J R Coll Physicians Lond. 1997 May-Jun;31(3):317-20.

37.

Risk of primary and recurrent acute myocardial infarction from lipoprotein(a)--II.

De Bono D.

J Am Coll Cardiol. 1997 Mar 15;29(4):887-8; author reply 888-9. No abstract available.

40.

[Use of PTCA in a gastroepiploic aortocoronary graft].

Kovác J, Murgatroyd FD, Verma PK, de Bono DP.

Vnitr Lek. 1997 Feb;43(2):98-101. Czech.

PMID:
9245077
41.

Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody.

Aggarwal RK, Ireland DC, Azrin MA, Ezekowitz MD, de Bono DP, Gershlick AH.

Circulation. 1996 Dec 15;94(12):3311-7.

PMID:
8989145
42.

Dynamics of QT dispersion during myocardial infarction and ischaemia.

Glancy JM, Garratt CJ, de Bono DP.

Int J Cardiol. 1996 Nov 15;57(1):55-60.

PMID:
8960944
43.

Early postoperative spasm of an internal thoracic artery bypass graft assessed by duplex ultrasound.

Nikodemska I, Sosnowski A, Uren NG, Spyt TJ, Reek C, De Bono DP.

Eur Heart J. 1996 Oct;17(10):1600-1. No abstract available.

PMID:
8909921
44.

Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty.

Samani NJ, Martin DS, Brack M, Cullen J, Wallis R, Lodwick D, Chauhan A, Harley A, Thompson JR, Gershlick AH, de Bono DP.

Atherosclerosis. 1996 Sep 6;125(2):209-16.

PMID:
8842352
45.
46.

Reproducibility and automatic measurement of QT dispersion.

Glancy JM, Weston PJ, Bhullar HK, Garratt CJ, Woods KL, de Bono DP.

Eur Heart J. 1996 Jul;17(7):1035-9.

PMID:
8809521
47.
48.

Prevention of coronary heart disease with pravastatin.

Samani NJ, de Bono DP.

N Engl J Med. 1996 May 16;334(20):1333-4; author reply 1334-5. No abstract available.

PMID:
8609957
49.

New training guidelines: what are the implications for cardiological research?

de Bono D, Gershlick AH, Samani NJ, Garratt CJ.

Heart. 1996 Feb;75(2):118-20.

Supplemental Content

Loading ...
Support Center